These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 35550621)
21. Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis. Mulenga H; Musvosvi M; Mendelsohn SC; Penn-Nicholson A; Kimbung Mbandi S; Fiore-Gartland A; Tameris M; Mabwe S; Africa H; Bilek N; Kafaar F; Khader SA; Carstens B; Hadley K; Hikuam C; Erasmus M; Jaxa L; Raphela R; Nombida O; Kaskar M; Nicol MP; Mbhele S; Van Heerden J; Innes C; Brumskine W; Hiemstra A; Malherbe ST; Hassan-Moosa R; Walzl G; Naidoo K; Churchyard G; Hatherill M; Scriba TJ; Am J Respir Crit Care Med; 2021 Dec; 204(12):1463-1472. PubMed ID: 34520313 [No Abstract] [Full Text] [Related]
22. Practices and attitudes towards tuberculosis and latent tuberculosis infection screening in people living with HIV/AIDS among HIV physicians in Japan. Kawatsu L; Kaneko N; Imahashi M; Kamada K; Uchimura K AIDS Res Ther; 2022 Dec; 19(1):60. PubMed ID: 36463211 [TBL] [Abstract][Full Text] [Related]
23. Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data. Karanja M; Kingwara L; Owiti P; Kirui E; Ngari F; Kiplimo R; Maina M; Masini E; Onyango E; Ngugi C PLoS One; 2020; 15(12):e0234588. PubMed ID: 33264300 [TBL] [Abstract][Full Text] [Related]
24. Tuberculosis Preventive Treatment Scale-Up Among Antiretroviral Therapy Patients - 16 Countries Supported by the U.S. President's Emergency Plan for AIDS Relief, 2017-2019. Melgar M; Nichols C; Cavanaugh JS; Kirking HL; Surie D; Date A; Ahmedov S; Maloney S; Fukunaga R; ; MMWR Morb Mortal Wkly Rep; 2020 Mar; 69(12):329-334. PubMed ID: 32214084 [TBL] [Abstract][Full Text] [Related]
25. Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature. Briggs MA; Emerson C; Modi S; Taylor NK; Date A J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S297-305. PubMed ID: 25768869 [TBL] [Abstract][Full Text] [Related]
26. Modeling the impact of universal tuberculosis molecular testing and timing of tuberculosis preventive treatment during antiretroviral therapy initiation in South Africa. Balasubramanian R; Shearer K; Mudzengi D; Hippner P; Golub JE; Chihota V; Hoffmann CJ; Kendall EA AIDS; 2023 Dec; 37(15):2371-2379. PubMed ID: 37650763 [TBL] [Abstract][Full Text] [Related]
27. Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries. Harries AD; Schwoebel V; Monedero-Recuero I; Aung TK; Chadha S; Chiang CY; Conradie F; Dongo JP; Heldal E; Jensen P; Nyengele JPK; Koura KG; Kumar AMV; Lin Y; Mlilo N; Nakanwagi-Mukwaya A; Ncube RT; Nyinoburyo R; Oo NL; Patel LN; Piubello A; Rusen ID; Sanda T; Satyanarayana S; Syed I; Thu AS; Tonsing J; Trébucq A; Zamora V; Zishiri C; Hinderaker SG; Aït-Khaled N; Roggi A; Caminero Luna J; Graham SM; Dlodlo RA; Fujiwara PI Int J Tuberc Lung Dis; 2019 Feb; 23(2):241-251. PubMed ID: 30808459 [TBL] [Abstract][Full Text] [Related]
28. Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial. Semitala FC; Kadota JL; Musinguzi A; Nabunje J; Welishe F; Nakitende A; Akello L; Bishop O; Patel D; Sammann A; Nahid P; Belknap R; Kamya MR; Handley MA; Phillips PPJ; Katahoire A; Berger CA; Kiwanuka N; Katamba A; Dowdy DW; Cattamanchi A PLoS Med; 2021 Dec; 18(12):e1003875. PubMed ID: 34914696 [TBL] [Abstract][Full Text] [Related]
29. Early-phase scale-up of isoniazid preventive therapy for people living with HIV in two districts in Malawi (2017). Nabity SA; Gunde LJ; Surie D; Shiraishi RW; Kirking HL; Maida A; Auld AF; Odo M; Jahn A; Nyirenda RK; Oeltmann JE PLoS One; 2021; 16(4):e0248115. PubMed ID: 33793577 [TBL] [Abstract][Full Text] [Related]
30. Programmatic Evaluation of an Algorithm for Intensified Tuberculosis Case Finding and Isoniazid Preventive Therapy for People Living With HIV in Thailand and Vietnam. Cowger TL; Thai LH; Duong BD; Danyuttapolchai J; Kittimunkong S; Nhung NV; Nhan DT; Monkongdee P; Thoa CK; Khanh VT; Nateniyom S; Yen NTB; Ngoc DV; Thinh T; Whitehead S; Pevzner ES J Acquir Immune Defic Syndr; 2017 Dec; 76(5):512-521. PubMed ID: 29023251 [TBL] [Abstract][Full Text] [Related]
31. The Drinkers' Intervention to Prevent Tuberculosis (DIPT) trial among heavy drinkers living with HIV in Uganda: study protocol of a 2×2 factorial trial. Lodi S; Emenyonu NI; Marson K; Kwarisiima D; Fatch R; McDonell MG; Cheng DM; Thirumurthy H; Gandhi M; Camlin CS; Muyindike WR; Hahn JA; Chamie G Trials; 2021 May; 22(1):355. PubMed ID: 34016158 [TBL] [Abstract][Full Text] [Related]
32. Gaps in TB preventive therapy for persons initiating antiretroviral therapy in Uganda: an explanatory sequential cascade analysis. Kalema N; Semeere A; Banturaki G; Kyamugabwa A; Ssozi S; Ggita J; Kabajaasi O; Kambugu A; Kigozi J; Muganzi A; Castelnuovo B; Cattamanchi A; Armstrong-Hough M Int J Tuberc Lung Dis; 2021 May; 25(5):388-394. PubMed ID: 33977907 [No Abstract] [Full Text] [Related]
33. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia. Yirdaw KD; Jerene D; Gashu Z; Edginton ME; Kumar AM; Letamo Y; Feleke B; Teklu AM; Zewdu S; Weiss B; Ruff A PLoS One; 2014; 9(8):e104557. PubMed ID: 25105417 [TBL] [Abstract][Full Text] [Related]
34. Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda-patient and health worker perspectives. Semitala FC; Musinguzi A; Ssemata J; Welishe F; Nabunje J; Kadota JL; Berger CA; Katamba A; Kiwanuka N; Kamya MR; Dowdy D; Cattamanchi A; Katahoire AR Implement Sci Commun; 2021 Jun; 2(1):71. PubMed ID: 34193311 [TBL] [Abstract][Full Text] [Related]
35. Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness. Nsengiyumva NP; Campbell JR; Oxlade O; Vesga JF; Lienhardt C; Trajman A; Falzon D; Den Boon S; Arinaminpathy N; Schwartzman K PLoS Med; 2022 Jun; 19(6):e1004032. PubMed ID: 35696431 [TBL] [Abstract][Full Text] [Related]
36. Leveraging differentiated HIV service delivery to expand tuberculosis preventive treatment: a call to action. Rabkin M; Howard AA; Ehrenkranz P; Fernandez LG; Preko P; Singh V; Tomlinson HL; El-Sadr WM Int J Tuberc Lung Dis; 2020 Feb; 24(2):165-169. PubMed ID: 32127099 [TBL] [Abstract][Full Text] [Related]
37. A stool based qPCR for the diagnosis of TB in children and people living with HIV in Uganda, Eswatini and Mozambique (Stool4TB): a protocol for a multicenter diagnostic evaluation. Carratala-Castro L; Ssengooba W; Kay A; Acácio S; Ehrlich J; DiNardo AR; Shiba N; Nsubuga JK; Munguambe S; Saavedra-Cervera B; Manjate P; Mulengwa D; Sibandze B; Ziyane M; Kasule G; Mambuque E; Sekadde MP; Wobudeya E; Joloba ML; Heyckendorf J; Lange C; Hermans S; Mandalakas A; García-Basteiro AL; Lopez-Varela E; BMC Infect Dis; 2024 Feb; 24(1):233. PubMed ID: 38383310 [TBL] [Abstract][Full Text] [Related]
38. Landscape of TB Infection and Prevention among People Living with HIV. Vasiliu A; Abelman R; Kherabi Y; Iswari Saktiawati AM; Kay A Pathogens; 2022 Dec; 11(12):. PubMed ID: 36558886 [TBL] [Abstract][Full Text] [Related]
39. Point-of-care C-reactive protein testing to facilitate implementation of isoniazid preventive therapy for people living with HIV. Yoon C; Davis JL; Huang L; Muzoora C; Byakwaga H; Scibetta C; Bangsberg DR; Nahid P; Semitala FC; Hunt PW; Martin JN; Cattamanchi A J Acquir Immune Defic Syndr; 2014 Apr; 65(5):551-6. PubMed ID: 24346636 [TBL] [Abstract][Full Text] [Related]
40. Screening and testing for tuberculosis among the HIV-infected: outcomes from a large HIV programme in western Kenya. Owiti P; Onyango D; Momanyi R; Harries AD BMC Public Health; 2019 Jan; 19(1):29. PubMed ID: 30621655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]